ReviewInternational journal of clinical oncology2025

Adjuvant and neo-adjuvant therapy for non-small cell lung cancer without EGFR mutations or ALK rearrangements.

Masaru Takenaka et al.PubMed ↗Publisher ↗

No numbers read from the abstract.